Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Clinical trial NCT02618915 · TERMINATED
Trial details
- NCT number
- NCT02618915
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-16
- Primary completion
- 2017-10-18
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.